BIOTON S.A. (FRA:7U5)

Market Cap	79.52M -6.6%
Revenue (ttm)	61.93M +12.8%
Net Income	942.78K
EPS	0.01
Shares Out	n/a
PE Ratio	84.34
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.8660
Previous Close	0.8520
Day's Range	0.8660 - 0.8660
52-Week Range	0.8520 - 1.1500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 15, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 363
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7U5

Financial Performance

Financial numbers in PLN

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error